Did you know?

Net Product Revenues: $21.6 million for Q1 2024, up 59% from Q4 2023. Gross to Net Percentage: Improved to low 60%s. R&D Expenses: $23.8 million for Q1 …Dec 13, 2023 · Arcutis Biotherapeutics (ARQT) Mizuho Securities analyst Uy Ear maintained a Hold rating on Arcutis Biotherapeutics on December 8 and set a price target of $4.00. The company’s shares closed ... ARQT's short-term technical score of 27 indicates that the stock has traded less bullishly over the last month than 73% of stocks on the market. In the Biotechnology industry, which ranks 123 out of 146 industries, Arcutis Biotherapeutics Inc ranks higher than 43% of stocks. Arcutis Biotherapeutics Inc has risen 19.61% over the past month ... Get the latest stock market research, news and analyst forecasts for ARQT. Follow the stock price, chart, stats and ratings on TipRanks.com. ARQT Competitors. $ Market cap P/E ratio $ Price 1d change 52-week range. View Arcutis Biotherapeutics Inc ARQT stock quote prices, financial information, real-time forecasts, and company news ... Fintel reports that on January 2, 2024, Mizuho upgraded their outlook for Arcutis Biotherapeutics ( NasdaqGS:ARQT) from Neutral to Buy . Analyst Price Forecast Suggests 232.07% Upside. As of ...Track ArQule Inc. (ARQL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Shares of Arcutis Biotherapeutics (NASDAQ:ARQT) rallied 20% in after-hours trading Friday on news that the FDA had approved the company’s drug Zoryve, also known as roflumilast, for the ... ARQT rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results. Arcutis Biotherapeutics reported …Track American Virtual Cloud Technologies Inc (AVCTQ) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack ARS Pharmaceuticals Inc (SPRY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsAccording to the issued ratings of 8 analysts in the last year, the consensus rating for Arcutis Biotherapeutics stock is Moderate Buy based on the current 2 hold ratings and 6 buy ratings for ARQT. The average twelve-month price prediction for Arcutis Biotherapeutics is $26.56 with a high price target of $50.00 and a low price target of $8.00.Arcutis (ARQT) is a good speculative biotech play. It has already received FDA approval of ZORYVE and it has a PDUFA date expected for the end of 2023. See more here.2.28. 2.56. 2.56. 9,003,500. *Close price adjusted for splits. **Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data... Discover historical prices for ARQT stock on Yahoo Finance. View daily, weekly or monthly format back to when Arcutis Biotherapeutics, Inc. stock was issued.Track Arcturus Therapeutics Holdings Inc (ARCT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsMizuho Securities analyst Uy Ear maintained a Buy rating on Arcutis Biotherapeutics (ARQT – Research Report) today and set a price target ... Mizuho Securities analyst Uy Ear...Track Aridis Pharmaceuticals Inc (ARDS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Get the latest stock market research, news and analyst forecasts for ARQT. Follow the stock price, chart, stats and ratings on TipRanks.com. Shares of Arcutis Biotherapeutics (NASDAQ:ARQT) rallied 20% in after-hours trading Friday on news that the FDA had approved the company’s drug Zoryve, also known as roflumilast, for the ... Arcutis Biotherapeutics reported earnings per share of -32 cents. This was above the analyst estimate for EPS of -73 cents. The company reported revenue of …8.28%. $11.91B. Eisai Co. Ltd. -0.43%. ¥1.94T. ARQT | Complete Arcutis Biotherapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Find the latest Arcutis Biotherapeutics, Inc. (ARQT) stock quote, history, news and other vital information to help you with your stock trading and investing.Get the latest Arqit Quantum Inc. (ARQQ) stock news and headlines to help you in your trading and investing decisions.ARQT: Arcutis Biotherapeutics Inc - Stock Price, Quote and News - CNBC. Earnings Announcement After Market Close. Arcutis Biotherapeutics Inc ARQT:NASDAQ. …

A high-level overview of Morphic Holding, Inc. (MORF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Track KULR Technology Group Inc (KULR) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsMac OS X only: System utility Loginox makes short work of changing your Mac's login wallpaper to anything you want. Mac OS X only: System utility Loginox makes short work of changi...Arcutis (ARQT) is a good speculative biotech play. It has already received FDA approval of ZORYVE and it has a PDUFA date expected for the end of 2023. See more here.

Track American Battery Technology Company (ABAT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack Adc Therapeutics SA (ADCT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors ARQT Competitors. $ Market cap P/E ratio $ Price 1d change 52-week range. View Arcutis Biotherapeutics Inc ARQT stock quote prices, financial information, real-time forecasts, and company news ... …

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. A high-level overview of Arcutis Biotherap. Possible cause: Track Arista Networks Inc (ANET) Stock Price, Quote, latest community messages, chart, new.